{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:45:26Z","timestamp":1791935126241,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48068-3","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:55:32Z","timestamp":1776477332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of new liposomal formulations of quercetin \u2013 in vitro study"],"prefix":"10.1038","volume":"16","author":[{"given":"Klaudia","family":"Krawczy\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Rusak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"G\u00f3rnicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Mrozowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Dzi\u0119giel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Gubernator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"48068_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16122262","author":"RM Slominski","year":"2024","unstructured":"Slominski, R. M. et al. Malignant melanoma: An overview, new perspectives, and vitamin D signaling. Cancers https:\/\/doi.org\/10.3390\/cancers16122262 (2024).","journal-title":"Cancers"},{"key":"48068_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/647684","author":"F Tas","year":"2012","unstructured":"Tas, F. Metastatic behavior in melanoma: Timing, pattern, survival, and influencing factors. J. Oncol. https:\/\/doi.org\/10.1155\/2012\/647684 (2012).","journal-title":"J. Oncol."},{"issue":"3","key":"48068_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74(3), 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"48068_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold, M. et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 158(5), 495\u2013503. https:\/\/doi.org\/10.1001\/jamadermatol.2022.0160 (2022).","journal-title":"JAMA Dermatol."},{"key":"48068_CR5","doi-asserted-by":"publisher","DOI":"10.1017\/anr.2024.2","author":"Y Li","year":"2024","unstructured":"Li, Y., Han, N., Hou, P., Zhao, F.-Q. & Liu, H. Roles of MAPK and Nrf2 signaling pathways in quercetin alleviating redox imbalance induced by hydrogen peroxide in mammary epithelial cells. Anim. Nutriomics https:\/\/doi.org\/10.1017\/anr.2024.2 (2024).","journal-title":"Anim. Nutriomics"},{"key":"48068_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03220-9","author":"MY Hsieh","year":"2024","unstructured":"Hsieh, M. Y., Hsu, S. K., Liu, T. Y., Wu, C. Y. & Chiu, C. C. Melanoma biology and treatment: A review of novel regulated cell death-based approaches. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-024-03220-9 (2024).","journal-title":"Cancer Cell Int."},{"issue":"5","key":"48068_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13051115","volume":"13","author":"M Patel","year":"2021","unstructured":"Patel, M. et al. Resistance to molecularly targeted therapies in melanoma. Cancers 13(5), 1\u201326. https:\/\/doi.org\/10.3390\/cancers13051115 (2021).","journal-title":"Cancers"},{"key":"48068_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164026","author":"G Castellani","year":"2023","unstructured":"Castellani, G. et al. BRAF mutations in melanoma: Biological aspects, therapeutic implications, and circulating biomarkers. Cancers https:\/\/doi.org\/10.3390\/cancers15164026 (2023).","journal-title":"Cancers"},{"key":"48068_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030918","author":"E Madej","year":"2023","unstructured":"Madej, E. et al. Vemurafenib and dabrafenib downregulates RIPK4 level. Cancers https:\/\/doi.org\/10.3390\/cancers15030918 (2023).","journal-title":"Cancers"},{"issue":"21","key":"48068_CR10","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.18632\/oncotarget.2602","volume":"5","author":"F Spagnolo","year":"2014","unstructured":"Spagnolo, F., Ghiorzo, P. & Queirolo, P. Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma. Oncotarget 5 (21), 10206\u201310221. https:\/\/doi.org\/10.18632\/oncotarget.2602 (2014).","journal-title":"Oncotarget"},{"key":"48068_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071823","author":"I Proietti","year":"2020","unstructured":"Proietti, I. et al. BRAF inhibitors: Molecular targeting and immunomodulatory actions. Cancers https:\/\/doi.org\/10.3390\/cancers12071823 (2020).","journal-title":"Cancers"},{"issue":"1","key":"48068_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/CMR.0000000000000527","volume":"29","author":"JZ Drago","year":"2019","unstructured":"Drago, J. Z. et al. Clinical experience with combination BRAF\/MEK inhibitors for melanoma with brain metastases: A real-life multicenter study. Melanoma Res. 29(1), 65\u201369. https:\/\/doi.org\/10.1097\/CMR.0000000000000527 (2019).","journal-title":"Melanoma Res."},{"key":"48068_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091342","author":"T Fujimura","year":"2019","unstructured":"Fujimura, T., Fujisawa, Y., Kambayashi, Y. & Aiba, S. Significance of BRAF kinase inhibitors for melanoma treatment: From bench to bedside. Cancers https:\/\/doi.org\/10.3390\/cancers11091342 (2019).","journal-title":"Cancers"},{"issue":"9","key":"48068_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.trecan.2020.05.009","volume":"6","author":"V Subbiah","year":"2020","unstructured":"Subbiah, V., Baik, C. & Kirkwood, J. M. Clinical development of BRAF plus MEK inhibitor combinations. Trends Cancer 6(9), 797\u2013810. https:\/\/doi.org\/10.1016\/j.trecan.2020.05.009 (2020).","journal-title":"Trends Cancer"},{"issue":"3","key":"48068_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40257-021-00593-9","volume":"22","author":"DC Ziogas","year":"2021","unstructured":"Ziogas, D. C., Konstantinou, F., Bouros, S., Theochari, M. & Gogas, H. Combining BRAF\/MEK inhibitors with immunotherapy in the treatment of metastatic melanoma. Am. J. Clin. Dermatol. 22(3), 301\u2013314. https:\/\/doi.org\/10.1007\/s40257-021-00593-9 (2021).","journal-title":"Am. J. Clin. Dermatol."},{"issue":"1","key":"48068_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.taap.2007.04.004","volume":"222","author":"AW Boots","year":"2007","unstructured":"Boots, A. W. et al. The quercetin paradox. Toxicol. Appl. Pharmacol. 222(1), 89\u201396. https:\/\/doi.org\/10.1016\/j.taap.2007.04.004 (2007).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"48068_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29051000","author":"EJ Carrillo-Martinez","year":"2024","unstructured":"Carrillo-Martinez, E. J., Flores-Hern\u00e1ndez, F. Y., Salazar-Montes, A. M., Nario-Chaidez, H. F. & Hern\u00e1ndez-Ortega, L. D. Quercetin, a flavonoid with great pharmacological capacity. Molecules https:\/\/doi.org\/10.3390\/molecules29051000 (2024).","journal-title":"Molecules"},{"issue":"1","key":"48068_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s13346-019-00674-7","volume":"10","author":"KTJ Chen","year":"2020","unstructured":"Chen, K. T. J. et al. Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use. Drug Deliv. Transl. Res. 10(1), 202\u2013215. https:\/\/doi.org\/10.1007\/s13346-019-00674-7 (2020).","journal-title":"Drug Deliv. Transl. Res."},{"key":"48068_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/inorganics11020056","author":"I Kostova","year":"2023","unstructured":"Kostova, I. The role of complexes of biogenic metals in living organisms. Inorganics https:\/\/doi.org\/10.3390\/inorganics11020056 (2023).","journal-title":"Inorganics"},{"issue":"11","key":"48068_CR20","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/1071576021000016463","volume":"36","author":"L Mira","year":"2002","unstructured":"Mira, L. et al. Interactions of flavonoids with iron and copper ions: A mechanism for their antioxidant activity. Free Radic. Res. 36(11), 1199\u20131208. https:\/\/doi.org\/10.1080\/1071576021000016463 (2002).","journal-title":"Free Radic. Res."},{"issue":"SPEC. ISS.","key":"48068_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.molstruc.2004.11.081","volume":"744\u2013747","author":"A Torreggiani","year":"2005","unstructured":"Torreggiani, A., Tamba, M., Trinchero, A. & Bonora, S. Copper(II)-quercetin complexes in aqueous solutions: Spectroscopic and kinetic properties. J. Mol. Struct. 744\u2013747(SPEC. ISS.), 759\u2013766. https:\/\/doi.org\/10.1016\/j.molstruc.2004.11.081 (2005).","journal-title":"J. Mol. Struct."},{"issue":"1","key":"48068_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10534-010-9372-7","volume":"24","author":"A P\u0229kal","year":"2011","unstructured":"P\u0229kal, A., Biesaga, M. & Pyrzynska, K. Interaction of quercetin with copper ions: Complexation, oxidation and reactivity towards radicals. BioMetals 24 (1), 41\u201349. https:\/\/doi.org\/10.1007\/s10534-010-9372-7 (2011).","journal-title":"BioMetals"},{"key":"48068_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.fct.2017.10.042","volume":"110","author":"K Jomova","year":"2017","unstructured":"Jomova, K. et al. Protective role of quercetin against copper(II)-induced oxidative stress: A spectroscopic, theoretical and DNA damage study. Food Chem. Toxicol. 110, 340\u2013350. https:\/\/doi.org\/10.1016\/j.fct.2017.10.042 (2017).","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"48068_CR24","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1080\/13813455.2020.1773864","volume":"128","author":"M Najafi","year":"2022","unstructured":"Najafi, M., Tavakol, S., Zarrabi, A. & Ashrafizadeh, M. Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: A review. Arch. Physiol. Biochem. 128(6), 1438\u20131452. https:\/\/doi.org\/10.1080\/13813455.2020.1773864 (2022).","journal-title":"Arch. Physiol. Biochem."},{"key":"48068_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05572-7","author":"A Shi","year":"2024","unstructured":"Shi, A., Liu, L., Li, S. & Qi, B. Natural products targeting the MAPK-signaling pathway in cancer: Overview. J. Cancer Res. Clin. Oncol. https:\/\/doi.org\/10.1007\/s00432-023-05572-7 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"48068_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3233\/CLO-2008-0441","volume":"30","author":"T Thangasamy","year":"2008","unstructured":"Thangasamy, T., Sittadjody, S., Limesand, H., Burd, R. & K., & Tyrosinase overexpression promotes ATM-dependent p53 phosphorylation by quercetin and sensitizes melanoma cells to dacarbazine. Cell. Oncol. 30 (5), 371\u2013387. https:\/\/doi.org\/10.3233\/CLO-2008-0441 (2008).","journal-title":"Cell. Oncol."},{"key":"48068_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","volume":"5","author":"K Elumalai","year":"2024","unstructured":"Elumalai, K., Srinivasan, S. & Shanmugam, A. Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomed. Tech. 5, 109\u2013122. https:\/\/doi.org\/10.1016\/j.bmt.2023.09.001 (2024).","journal-title":"Biomed. Tech."},{"issue":"3","key":"48068_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.30476\/IJMS.2022.95272.2658","volume":"48","author":"F Keshavarz","year":"2023","unstructured":"Keshavarz, F. et al. Quercetin-loaded liposomes effectively induced apoptosis and decreased the epidermal growth factor receptor expression in colorectal cancer cells: An in vitro study. Iran. J. Med. Sci. 48(3), 321\u2013328. https:\/\/doi.org\/10.30476\/IJMS.2022.95272.2658 (2023).","journal-title":"Iran. J. Med. Sci."},{"key":"48068_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/J.FOODHYD.2018.03.006","volume":"81","author":"J Azzi","year":"2018","unstructured":"Azzi, J., Jraij, A., Auezova, L., Fourmentin, S. & Greige-Gerges, H. Novel findings for quercetin encapsulation and preservation with cyclodextrins, liposomes, and drug-in-cyclodextrin-in-liposomes. Food Hydrocolloids 81, 328\u2013340. https:\/\/doi.org\/10.1016\/J.FOODHYD.2018.03.006 (2018).","journal-title":"Food Hydrocolloids"},{"issue":"3","key":"48068_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.106.3.761","volume":"106","author":"P Boukamp","year":"1988","unstructured":"Boukamp, P. et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106(3), 761\u2013771. https:\/\/doi.org\/10.1083\/jcb.106.3.761 (1988).","journal-title":"J. Cell Biol."},{"issue":"1","key":"48068_CR31","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","volume":"13","author":"AD Bangham","year":"1965","unstructured":"Bangham, A. D., Standish, M. M. & Watkins, J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13(1), 238-IN27. https:\/\/doi.org\/10.1016\/S0022-2836(65)80093-6 (1965).","journal-title":"J. Mol. Biol."},{"issue":"1","key":"48068_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0003-2697(80)90269-9","volume":"104","author":"JCM Stewart","year":"1980","unstructured":"Stewart, J. C. M. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 104(1), 10\u201314. https:\/\/doi.org\/10.1016\/0003-2697(80)90269-9 (1980).","journal-title":"Anal. Biochem."},{"key":"48068_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11020069","author":"ML Moy\u00e1","year":"2019","unstructured":"Moy\u00e1, M. L. et al. Preparation and characterization of new liposomes. Bactericidal activity of cefepime encapsulated into cationic liposomes. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics11020069 (2019).","journal-title":"Pharmaceutics"},{"key":"48068_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114520","author":"A Rusak","year":"2023","unstructured":"Rusak, A. et al. Multimodal study of CHI3L1 inhibition and its effect on angiogenesis, migration, immune response and refractive index of cellular structures in glioblastoma. Biomed. Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2023.114520 (2023).","journal-title":"Biomed. Pharmacother."},{"issue":"3\/4","key":"48068_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2307\/2333709","volume":"52","author":"SS Shapiro","year":"1965","unstructured":"Shapiro, S. S. & Wilk, M. B. An analysis of variance test for normality (Complete Samples). Biometrika 52(3\/4), 591\u2013611. https:\/\/doi.org\/10.2307\/2333709 (1965).","journal-title":"Biometrika"},{"issue":"3","key":"48068_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/00401706.1964.10490181","volume":"6","author":"OJ Dunn","year":"1964","unstructured":"Dunn, O. J. Multiple comparisons using rank sums. Technometrics 6(3), 241\u2013252. https:\/\/doi.org\/10.1080\/00401706.1964.10490181 (1964).","journal-title":"Technometrics"},{"issue":"20","key":"48068_CR37","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.2174\/09298673113209990120","volume":"20","author":"X Cai","year":"2013","unstructured":"Cai, X., Fang, Z., Dou, J., Yu, A. & Zhai, G. Bioavailability of quercetin: Problems and promises. Curr. Med. Chem. 20(20), 2572\u20132582. https:\/\/doi.org\/10.2174\/09298673113209990120 (2013).","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"48068_CR38","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.fct.2007.09.002","volume":"46","author":"U Kaindl","year":"2008","unstructured":"Kaindl, U., Eyberg, I., Rohr-Udilova, N., Heinzle, C. & Marian, B. The dietary antioxidants resveratrol and quercetin protect cells from exogenous pro-oxidative damage. Food Chem. Toxicol. 46 (4), 1320\u20131326. https:\/\/doi.org\/10.1016\/j.fct.2007.09.002 (2008).","journal-title":"Food Chem. Toxicol."},{"key":"48068_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOPHA.2025.118055","volume":"187","author":"MK Lawson","year":"2025","unstructured":"Lawson, M. K. Copper-quercetin complexes: Methods of study, relevance to cell death pathways, therapeutic applications. Biomed. Pharmacother. 187, 118055. https:\/\/doi.org\/10.1016\/J.BIOPHA.2025.118055 (2025).","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"48068_CR40","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bcp.2013.11.008","volume":"87","author":"HH Cao","year":"2014","unstructured":"Cao, H. H. et al. Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem. Pharmacol. 87(3), 424\u2013434. https:\/\/doi.org\/10.1016\/j.bcp.2013.11.008 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"48068_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.phymed.2018.09.224","volume":"52","author":"NS Srivastava","year":"2019","unstructured":"Srivastava, N. S. & Srivastava, R. A. K. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt\/\u03b2-catenin signaling and apoptotic pathways in A375 cells. Phytomedicine 52, 117\u2013128. https:\/\/doi.org\/10.1016\/j.phymed.2018.09.224 (2019).","journal-title":"Phytomedicine"},{"key":"48068_CR42","doi-asserted-by":"publisher","unstructured":"Harris, Z., Donovan, M. G., Branco, G. M., Limesand, K. H. & Burd, R. Quercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development Strategy. Front. Nutr. 3 (October). https:\/\/doi.org\/10.3389\/fnut.2016.00048 (2016).","DOI":"10.3389\/fnut.2016.00048"},{"issue":"12","key":"48068_CR43","doi-asserted-by":"publisher","first-page":"6210","DOI":"10.1073\/pnas.94.12.6210","volume":"94","author":"R Halaban","year":"1997","unstructured":"Halaban, R. et al. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells. Proc. Natl. Acad. Sci. U. S. A. 94(12), 6210\u20136215. https:\/\/doi.org\/10.1073\/pnas.94.12.6210 (1997).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"48068_CR44","doi-asserted-by":"publisher","unstructured":"Patel, A. S. S. K. & Garg, N. P. K. K. C. D. D. V. R. S. T. T. R. G. N. M., Quercetin acts as a P-gp modulator via impeding signal transduction from nucleotide-binding domain to transmembrane domain. Journal of Biomolecular Structure and Dynamics, 40(10), 4507\u20134515. (2022). https:\/\/doi.org\/10.1080\/07391102.2020.1858966","DOI":"10.1080\/07391102.2020.1858966"},{"issue":"1","key":"48068_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87292-1","volume":"15","author":"LH Alfarsi","year":"2025","unstructured":"Alfarsi, L. H. et al. SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer. Sci. Rep. 15(1), 2805. https:\/\/doi.org\/10.1038\/s41598-025-87292-1 (2025).","journal-title":"Sci. Rep."},{"key":"48068_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173185","volume":"881","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Quercetin overcomes colon cancer cells resistance to chemotherapy by inhibiting solute carrier family 1, member 5 transporter. Eur. J. Pharmacol. 881, 173185. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173185 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"48068_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25143271","author":"N Or\u0161oli\u0107","year":"2020","unstructured":"Or\u0161oli\u0107, N., Odeh, D., Jembrek, M. J., Kne\u017eevi\u0107, J. & Ku\u010dan, D. Interactions between cisplatin and quercetin at physiological and hyperthermic conditions on cancer cells in vitro and in vivo. Molecules https:\/\/doi.org\/10.3390\/molecules25143271 (2020).","journal-title":"Molecules"},{"key":"48068_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/life14121685","author":"A Roman","year":"2024","unstructured":"Roman, A. et al. Quercetin enhances 5-fluorouracil-driven cytotoxicity dose-dependently in A375 human melanoma cells. Life https:\/\/doi.org\/10.3390\/life14121685 (2024).","journal-title":"Life"},{"issue":"1","key":"48068_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-282","volume":"10","author":"T Thangasamy","year":"2010","unstructured":"Thangasamy, T. et al. Quercetin abrogates chemoresistance in melanoma cells by modulating \u0394Np73. BMC Cancer 10(1), 282. https:\/\/doi.org\/10.1186\/1471-2407-10-282 (2010).","journal-title":"BMC Cancer"},{"key":"48068_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s43088-024-00566-x","author":"DM Anwar","year":"2024","unstructured":"Anwar, D. M., Hedeya, H. Y., Ghozlan, S. H., Ewas, B. M. & Khattab, S. N. Surface-modified lipid-based nanocarriers as a pivotal delivery approach for cancer therapy: Application and recent advances in targeted cancer treatment\u200f. Beni-Suef Univ. J. Basic Appl. Sci. https:\/\/doi.org\/10.1186\/s43088-024-00566-x (2024).","journal-title":"Beni-Suef Univ. J. Basic Appl. Sci."},{"issue":"5","key":"48068_CR52","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1203\/PDR.0b013e3181d601c5","volume":"67","author":"N Federman","year":"2010","unstructured":"Federman, N. & Denny, C. T. Targeting liposomes toward novel pediatric anticancer therapeutics. Pediatr. Res. 67(5), 514\u2013519. https:\/\/doi.org\/10.1203\/PDR.0b013e3181d601c5 (2010).","journal-title":"Pediatr. Res."},{"key":"48068_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2021.105084","author":"P Lima","year":"2021","unstructured":"Lima, P., Butera, A. P., Cabe\u00e7a, L. F. & Ribeiro-Viana, R. M. Liposome surface modification by phospholipid chemical reactions. Chem. Phys. Lipids https:\/\/doi.org\/10.1016\/j.chemphyslip.2021.105084 (2021).","journal-title":"Chem. Phys. Lipids"},{"issue":"7","key":"48068_CR54","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nsmb.1455","volume":"15","author":"LV Chernomordik","year":"2008","unstructured":"Chernomordik, L. V. & Kozlov, M. M. Mechanics of membrane fusion. Nat. Struct. Mol. Biol. 15(7), 675\u2013683. https:\/\/doi.org\/10.1038\/nsmb.1455 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"10","key":"48068_CR55","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/j.bbamem.2009.06.022","volume":"1788","author":"SD Li","year":"2009","unstructured":"Li, S. D. & Huang, L. Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer. Biochimica et Biophysica Acta (BBA) - Biomembranes 1788(10), 2259\u20132266. https:\/\/doi.org\/10.1016\/j.bbamem.2009.06.022 (2009).","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"48068_CR56","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b05679","author":"Y Tang","year":"2019","unstructured":"Tang, Y. et al. Overcoming the reticuloendothelial system barrier to drug delivery with a \u201cdon\u2019t-Eat-Us\u201d strategy. ACS Nano https:\/\/doi.org\/10.1021\/acsnano.9b05679 (2019).","journal-title":"ACS Nano"},{"key":"48068_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48838-5","author":"IV Zelepukin","year":"2024","unstructured":"Zelepukin, I. V., Shevchenko, K. G. & Deyev, S. M. Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-024-48838-5 (2024).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48068-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48068-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48068-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:19:07Z","timestamp":1781648347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48068-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48068"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48068-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17953"}}